Shivalik Rasayan Limited

Shivalik Rasayan Allots 2.82 Lakh Shares & 9.48 Lakh Warrants on Preferential Basis

Shivalik Rasayan approved the allotment of 2,82,000 equity shares at ₹250 each for ₹7.05 crore. Additionally, 9,47,990 warrants were allotted at ₹250 each for ₹23.70 crore. These preferential allotments increase the paid-up equity share capital. The Board meeting was held on September 14, 2026.

Shivalik Rasayan Ltd. Announces 48th AGM on Sep 28, Invites Public for Roadshow

Shivalik Rasayan Limited will hold its 48th AGM on September 28, 2026. The company's CSR initiative has installed 78 check dams, conserving 9,500 crore liters of water. The 'Peehli Yatra' festival roadshow is scheduled for October 13-14, 2026. Managing Director P.K. Jain received the 'Udyog Ratna' award.

Shivalik Rasayan announces 48th AGM on Sep 28, 2026; Dividend Re 0.50/share

Shivalik Rasayan Limited will hold its 48th AGM on September 28, 2026. The company recommended a final dividend of Re 0.50 per equity share. The record date for dividend entitlement is September 21, 2026. Remote e-voting will be available from September 25 to September 27, 2026.

Shivalik Rasayan: Former Director Sells 25,000 Shares

Former Director of Shivalik Rasayan Limited, Mr. Sanjay Bansal, sold 25,000 equity shares on August 21, 2026. The sale, executed on the open market, was valued at ₹68.31 lakh. This transaction reduces his shareholding to 0.32% (50,000 shares). The company has submitted the disclosure as per SEBI's insider trading regulations.

Shivalik Rasayan Ltd.: EGM Approves Preferential Issuance of Equity Shares and Warrants

Shivalik Rasayan Limited's EGM on August 20, 2026, approved the preferential issuance of up to 3,72,000 equity shares and up to 9,48,000 convertible warrants. The resolutions passed with overwhelming support from shareholders.

Shivalik Rasayan Limited's EGM Approves Preferential Issue of Shares & Warrants

Shivalik Rasayan Limited's EGM on August 20, 2026, approved the preferential issuance of up to 3,72,000 equity shares to the public and up to 9,48,000 convertible warrants to promoters and the public. Both resolutions passed with overwhelming majority.

Shivalik Rasayan Ltd Holds EGM on Aug 20, 2026, Discusses Preferential Issue

Shivalik Rasayan Limited convened an EGM on August 20, 2026. Key resolutions included the preferential issuance of up to 3,72,000 equity shares to the public and up to 9,48,000 warrants to promoters and the public. Voting results are pending the scrutinizer's report.

Shivalik Rasayan Ltd. Publishes Un-Audited Financial Results for Q1 FY27

Shivalik Rasayan Limited announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors adopted these results on August 14, 2026. The company is also undertaking a tender process for the disposal of immovable properties valued at ₹6 crore.

Shivalik Rasayan submits Business Responsibility & Sustainability Report for FY 2025-26

Shivalik Rasayan Limited has submitted its Business Responsibility & Sustainability Report for FY 2025-26. The report covers the company's operations in agrochemicals and pharma APIs. It details the company's commitment to ESG principles, employee welfare, and environmental management. The company has paid-up capital of ₹7.87 Crores and reported a pending GST litigation of ₹1.18 Crores.

Shivalik Rasayan Ltd. Announces AGM on Sep 28, 2026, Record Date Sep 21 for Dividend

Shivalik Rasayan Limited will hold its 47th AGM on September 28, 2026. The Record Date for dividend payment is set for September 21, 2026. The dividend, if approved, will be paid from October 15, 2026.

Shivalik Rasayan Q1FY27 Results: Net Profit ₹265.52 Lakhs, Board Approves AGM & Dividend Plans

Shivalik Rasayan reported Q1FY27 standalone net profit of ₹265.52 Lakhs and consolidated net profit of ₹450.13 Lakhs. The Board approved the draft annual report and scheduled the 48th AGM for September 28, 2026. A final dividend of 10% (₹0.50 per share) is proposed.

Shivalik Rasayan: Former Director Sells 50,000 Shares

Former Director of Shivalik Rasayan Limited, Mr. Sanjay Bansal, plans to sell 50,000 equity shares from the open market. This transaction is in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015. The disclosure was made on August 5, 2026.

Shivalik Rasayan Board Approves FY26 Results, Recommends 10% Dividend

Shivalik Rasayan Limited's Board approved audited financial results for FY26 on May 27, 2026. A 10% final dividend (50 paise/share) was recommended. The company appointed new internal and cost auditors and reconstituted board committees following a director's resignation. Revised financial results were submitted to NSE to correct a missing note.

Shivalik Rasayan Ex-Director Sanjay Bansal Sells 60,000 Shares

Former Director Sanjay Bansal sold 60,000 equity shares of Shivalik Rasayan Limited for ₹1.55 crore on July 28, 2026. Following the sale, he holds 1,00,000 shares, representing 0.63% of the company's equity.

Shivalik Rasayan Announces EGM on Aug 20 to Discuss Corporate Actions

Shivalik Rasayan Limited will hold an EGM on August 20, 2026, in Dehradun. The meeting will focus on discussing and approving corporate actions such as restructuring and debt fundraising to enhance business growth and financial standing.

Shivalik Rasayan to hold EGM on Aug 20, 2026, for preferential issue of shares & warrants.

Shivalik Rasayan Limited will hold an EGM on August 20, 2026. The company plans to issue up to 3,72,000 equity shares at ₹250 each, raising ₹9.30 crore. Additionally, it will issue up to 9,48,000 warrants at ₹250 each, potentially raising ₹23.70 crore. Remote e-voting is open from August 17-19, 2026.

Shivalik Rasayan Approves ₹9.3 Cr Equity Issue & ₹23.7 Cr Warrant Issue

Shivalik Rasayan will issue 3,72,000 equity shares at ₹250 each, raising ₹9.30 crore. Additionally, 9,48,000 warrants will be issued at ₹250 each, raising ₹23.70 crore. These will be issued on a preferential basis. An EGM is scheduled for August 20, 2026, for approval.

Shivalik Rasayan approves ₹9.3 Cr Equity Issue & ₹23.7 Cr Warrant Issue

Shivalik Rasayan's Board approved issuing up to 3,72,000 equity shares for ₹9.30 crore and 9,48,000 warrants for ₹23.70 crore. The EGM is scheduled for August 20, 2026, to get shareholder approval.

Shivalik Rasayan: Trading Window Closed from July 1 for Q1 FY27 Results

Shivalik Rasayan Limited will close its trading window from July 01, 2026. This closure is in effect until the announcement of the un-audited financial results for the quarter ending June 2026 and two days post-announcement. The board meeting date for this purpose will be announced later.

Shivalik Rasayan Limited Files Yearly Promoter Disclosure Under SEBI Takeover Regulations

Shivalik Rasayan Limited filed its yearly disclosure under SEBI (SAST) Regulations, 2011. The filing was made by the promoter, Growel Remedies Limited, for the year ended March 31, 2026. This is a standard regulatory submission.

Shivalik Rasayan: Former Director Sells 40,000 Equity Shares

Shivalik Rasayan Limited announced that former Director Mr. Sanjay Bansal sold 40,000 equity shares from the open market. This disclosure is made in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Shivalik Rasayan Ltd. Files Audited Financial Results for Q4FY26

Shivalik Rasayan Limited's Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026. The results were published in Financial Express and Vir Arjun on May 28, 2026.

Shivalik Rasayan Board Approves FY26 Audited Results and Recommends 10% Dividend

Shivalik Rasayan Limited's Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. A final dividend of 10% is recommended, subject to shareholder approval. The company also appointed new Internal and Cost Auditors for FY27 and noted the resignation of a Non-Executive Director.

Shivalik Rasayan: Certificate filed under SEBI Reg. 74(5) for Q4 FY26

Shivalik Rasayan Limited filed a certificate under SEBI Regulation 74(5) for the quarter ending March 31, 2026. The company confirmed the dematerialization and rematerialization of securities. The registrar also certified that securities were listed and certificates were cancelled and updated in records.

Shivalik Rasayan Ltd. Announces Un-Audited Financial Results for Q3 FY26

Shivalik Rasayan Limited announced its un-audited financial results for the quarter ended December 31, 2025. The company's consolidated revenue for FY25 reached ₹1243 crore. Subsidiary Shivalik Rasayan Limited received the 'Pioneer in Pharma' award. The announcement also detailed various property auctions by ICICI Home Finance.

Shivalik Rasayan Q3FY26 Un-audited Results Approved; Net Profit ₹203.49 Cr

Shivalik Rasayan's Board approved Q3FY26 unaudited results on Feb 13, 2026. Standalone net profit for the quarter was ₹203.49 Lakhs. Nine-month standalone profit reached ₹544.63 Lakhs. Consolidated net profit for the quarter was ₹269.63 Lakhs, and for nine months was ₹761.06 Lakhs.

Shivalik Rasayan Approves Q3 FY26 Un-Audited Financial Results

Shivalik Rasayan Limited's Board approved the un-audited financial results for Q3 FY26. The company reported standalone net profit of ₹203.49 Lakhs and consolidated net profit of ₹269.63 Lakhs for the quarter ended December 31, 2025. The results also cover the nine-month period ended the same date.

Shivalik Rasayan files certificate under SEBI Regulations for Q3 FY26.

Shivalik Rasayan Limited confirms compliance with SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. The company's registrar has processed all dematerialization requests, ensuring certificates are cancelled and updated in records within 15 days.

Shivalik Rasayan: Trading Window Closed Jan 1, 2026, for Q3 FY26 Results

Shivalik Rasayan Limited will close its trading window from January 01, 2026. The window will reopen two days after the declaration of unaudited financial results for the quarter ending December 31, 2025. The Board Meeting date for this purpose will be announced later.

Shivalik Rasayan Director Gifts 62,650 Shares

Shivalik Rasayan Limited announced that Director Mr. Ashwani Kumar Sharma has gifted 62,650 equity shares. This transaction is in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015. The disclosure was made on December 22, 2025.

Shivalik Rasayan Limited Announces Publication of Un-Audited Financial Results for Quarter Ended September 30, 2025

Shivalik Rasayan Limited announced the publication of its un-audited financial results for the quarter ended September 30, 2025, which were adopted by the Board on November 14, 2025.

Shivalik Rasayan Reports Q2 & H1 FY26 Results: Revenue Up, But Net Profit Declines Significantly

Shivalik Rasayan announced Q2 & H1 FY26 results. Revenue increased, but standalone and consolidated net profits for both the quarter and half-year significantly declined year-on-year, indicating profitability challenges.

Shivalik Rasayan Approves Un-Audited Financial Results for Quarter Ended September 30, 2025

Shivalik Rasayan Limited's Board of Directors approved the Un-Audited Financial Results (Standalone and Consolidated) for the quarter & half year ended September 30, 2025.

Shivalik Rasayan receives warning letters from NSE & BSE for Audit Committee non-compliance

Shivalik Rasayan received warning letters from NSE and BSE for non-compliance with SEBI LODR regarding its Audit Committee quorum at a meeting on August 13, 2024, committing to corrective action.

Shivalik Rasayan files certificate for dematerialized securities for Q2 FY26

Shivalik Rasayan filed the required certificate under SEBI (Depositories and Participants) Regulations, 2018, for Q2 FY26, confirming dematerialization/rematerialization of securities.

Newspaper Publication under Regulation 47 of SEBI LODR

Shivalik Rasayan Limited publicized newspaper advertisements on October 09, 2025, in compliance with SEBI LODR regulations, as disclosed in their recent announcement.

Newspaper Publication for 47th Annual General Meeting

Shivalik Rasayan Reports Q1 FY26 Results, Plans New Pesticides Formulation Subsidiary